PTC Therapeutics Statistics
Total Valuation
PTCT has a market cap or net worth of $5.83 billion. The enterprise value is $6.62 billion.
Important Dates
The last earnings date was Thursday, May 7, 2026, after market close.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PTCT has 82.95 million shares outstanding. The number of shares has increased by 1.66% in one year.
| Current Share Class | 82.95M |
| Shares Outstanding | 82.95M |
| Shares Change (YoY) | +1.66% |
| Shares Change (QoQ) | +2.27% |
| Owned by Insiders (%) | 2.42% |
| Owned by Institutions (%) | 110.51% |
| Float | 73.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 116.30 |
| PS Ratio | 7.00 |
| Forward PS | 5.48 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.00 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.44
| Current Ratio | 2.44 |
| Quick Ratio | 2.29 |
| Debt / Equity | n/a |
| Debt / EBITDA | 5,863.90 |
| Debt / FCF | n/a |
| Interest Coverage | -0.40 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -1.54% |
| Return on Invested Capital (ROIC) | -11.26% |
| Return on Capital Employed (ROCE) | -3.49% |
| Weighted Average Cost of Capital (WACC) | 6.41% |
| Revenue Per Employee | $834,622 |
| Profits Per Employee | -$188,423 |
| Employee Count | 991 |
| Asset Turnover | 0.30 |
| Inventory Turnover | 10.71 |
Taxes
| Income Tax | -48.94M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +47.86% in the last 52 weeks. The beta is 0.53, so PTCT's price volatility has been lower than the market average.
| Beta (5Y) | 0.53 |
| 52-Week Price Change | +47.86% |
| 50-Day Moving Average | 68.88 |
| 200-Day Moving Average | 68.03 |
| Relative Strength Index (RSI) | 49.38 |
| Average Volume (20 Days) | 1,579,386 |
Short Selling Information
The latest short interest is 9.76 million, so 11.76% of the outstanding shares have been sold short.
| Short Interest | 9.76M |
| Short Previous Month | 8.55M |
| Short % of Shares Out | 11.76% |
| Short % of Float | 13.34% |
| Short Ratio (days to cover) | 9.17 |
Income Statement
In the last 12 months, PTCT had revenue of $827.11 million and -$186.73 million in losses. Loss per share was -$2.32.
| Revenue | 827.11M |
| Gross Profit | 306.42M |
| Operating Income | -67.91M |
| Pretax Income | -235.67M |
| Net Income | -186.73M |
| EBITDA | -20.90M |
| EBIT | -67.91M |
| Loss Per Share | -$2.32 |
Full Income StatementBalance Sheet
The company has $1.89 billion in cash and $2.72 billion in debt, with a net cash position of -$829.85 million or -$10.00 per share.
| Cash & Cash Equivalents | 1.89B |
| Total Debt | 2.72B |
| Net Cash | -829.85M |
| Net Cash Per Share | -$10.00 |
| Equity (Book Value) | -180.47M |
| Book Value Per Share | -2.18 |
| Working Capital | 1.33B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$217.95 million and capital expenditures -$8.33 million, giving a free cash flow of -$226.28 million.
| Operating Cash Flow | -217.95M |
| Capital Expenditures | -8.33M |
| Depreciation & Amortization | 47.01M |
| Net Borrowing | -1.61M |
| Free Cash Flow | -226.28M |
| FCF Per Share | -$2.73 |
Full Cash Flow StatementMargins
Gross margin is 37.05%, with operating and profit margins of -8.21% and -22.58%.
| Gross Margin | 37.05% |
| Operating Margin | -8.21% |
| Pretax Margin | -28.49% |
| Profit Margin | -22.58% |
| EBITDA Margin | -2.53% |
| EBIT Margin | -8.21% |
| FCF Margin | n/a |
Dividends & Yields
PTCT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.66% |
| Shareholder Yield | -1.66% |
| Earnings Yield | -3.23% |
| FCF Yield | -3.91% |
Analyst Forecast
The average price target for PTCT is $90.93, which is 29.48% higher than the current price. The consensus rating is "Buy".
| Price Target | $90.93 |
| Price Target Difference | 29.48% |
| Analyst Consensus | Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (5Y) | 1.53% |
| EPS Growth Forecast (5Y) | -2.69% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PTCT has an Altman Z-Score of 0.28 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.28 |
| Piotroski F-Score | 1 |
